Dana Blankenhorn

Dana Blankenhorn

InvestorPlace Contributor

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

Snap Is Sitting Out the Social Media Turmoil (and So Should You)

By Dana Blankenhorn, InvestorPlace Contributor

Snap now calls itself an "augmented reality" company rather than a social media one, emphasizing ad-backed services.

Clover Health’s Technology Is Great But With Dead Money

By Dana Blankenhorn, InvestorPlace Contributor

Clover Health has interesting technology, but unless it can end losses this year it may not have a 2023. It has great technology but may lack the financial strength to make it in the Medicare Advantage arena.

Why Berkshire Hathaway Stock is a Must-Have for Any Diversified Portfolio

By Dana Blankenhorn, InvestorPlace Contributor

Insurance is a great business in good and bad times, and BRK-A stock is the largest insurance stock in the world.

What Elon Musk Stands to Gain (or Lose) Amid Possible Twitter Buyout

By Dana Blankenhorn, InvestorPlace Contributor

Elon Musk is planning to take Twitter private at $54.20 per share. He has the money, but critics wonder if TWTR stock has the value.

Pfizer: What Comes After the Covid-19 Fire?

By Dana Blankenhorn, InvestorPlace Contributor

Pfizer now has a $31 billion warchest that incoming CFO David Denton must spend on treatments that can maintain its $8.7 billion per year dividend.

Load More